Edgen Stock·Nov 25 2025, 21:34返回
返回
诺和诺德股价因下一代肥胖症药物Amycretin的积极数据而飙升
Edgen Stock·Nov 25 2025, 21:34
[1] 诺和诺德药物帮助患者减肥，降低血糖... (https://www.wsj.com/health/pharma/novo-nordis ...)[2] 诺和诺德称新型糖尿病注射剂促使体重减轻14.5% - 彭博社 (https://www.bloomberg.com/news/articles/2025- ...)[3] 诺和诺德将下一代药物amycretin推向晚期糖尿病... (https://www.cnbc.com/2025/11/25/novos-next-ge ...)